Aslani, Rina H.
HRN: 13-46-83 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2022
CEFUROXIME 750MG (VIAL)
12/07/2022
12/13/2022
IVT
300 Mg
Q8h
UTI
Waiting Final Action